BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2020
View Archived Issues
Researchers achieve the reversal of HIV and SIV latency in vivo
Read More
Chromosome amplification drives cancer progression via effects on secretion
Read More
Fat or fiber, cFAP activation is problematic for heart
Read More
Novel panaxatriol derivative shows efficacy in rat model of MI/R injury
Read More
Phase Ia/b data presented for PL-MLP in patients with metastatic CRC
Read More
ALPN-101 demonstrates efficacy in preclinical models of chronic IBD
Read More
FDA issues clinical hold on the phase III POLAR program of PledOx
Read More
Colorectal cancer among those affected by periostin
Read More
CEPI awards funding to support development of vaccines against coronavirus 2019-nCoV
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui patent TLR8 agonists
Read More
Incyte describes new adenosine A2A and/or A2B receptor antagonists
Read More
PIKfyve inhibitors identified at MFMER, Sanford Burnham Prebys Medical Discovery Institute
Read More
Protein cereblon inhibitors discovered at Kymera Therapeutics
Read More
The University of Minnesota presents psi-glutathione compounds
Read More
PDE3A influences endothelial function and risk of ischemic stroke
Read More
Phase III study of AKP-01 spray in mild to moderate plaque psoriasis meets primary endpoint
Read More
Pivotal DESTINY-Gastric01 trial of DS-8201 meets primary endpoint
Read More
CStone begins phase III study of CS-1003 in advanced hepatocellular carcinoma
Read More
Dynacure studies DYN-101 in phase I/II trial for centronuclear myopathies
Read More
Brilinta improves outcomes after acute ischemic stroke or TIA in phase III trial
Read More
Phase I results with EPX-100 pave way for phase II studies in Dravet syndrome
Read More
Phase III BREEZE-AD4 trial of baricitinib in atopic dermatitis meets primary endpoint
Read More
Daiichi Sankyo begins phase I study in Japan with DS-2741a for atopic dermatitis
Read More